Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Raymond L. Benza, Harrison W. Farber, Mona Selej, Mardi Gomberg-Maitland. Assessing risk in pulmonary arterial hypertension: what we know, what we don't. Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017

Member's Comments

No comment yet.

Related content which might interest you: Pathophysiology of pulmonary hypertension: what the interested clinician needs to know Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021 Year: 2021 Clinical trials in pulmonary arterial hypertension: what they tell us Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 “Rehab for all!” Is it too early in pulmonary arterial hypertension? Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019 Year: 2019 Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015 Pulmonary hypertension: what does the pathology tell us? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 Sex differences in pulmonary hypertension: are we cleaning up the mess? Source: Eur Respir J 2016; 47: 390-393 Year: 2016 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing? Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019 Year: 2019 New guidelines for chronic cough: what we know and what we don’t know Source: International Congress 2019 – New clinical practice guidelines for chronic cough Year: 2019 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 Inflammation in pulmonary arterial hypertension: is it time to quell the fire? Source: Eur Respir J 2014; 43: 685-688 Year: 2014 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 CC6 Is it truly pulmonary arterial hypertension? Source: Milan 2017 - Educational material Year: 2017 What can the ECG tell us about pulmonary embolism? Source: Eur Respir J 2004; 24: Suppl. 48, 274s Year: 2004